Novel inhibitors of protein arginine methyltransferase 5 (PRMT5) for the treatment of solid tumors

Preclinical in vivo evaluation of efficacy, pharmacokinetics and pharmacodynamics of novel PRMT5 inhibitors in multiple tumor models (PRMT5i)